IFNB1 and melanoma: Because CCL17 and CCL22 from TAMs attracts Tregs to the tumor site in melanoma (7, 21, 22), repolarization of TAMs by immunomodulatory reagents such as IFN-β and imiquimod are useful for suppressing tumor growth in melanoma (7, 22).